1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
JPMorgan Chase released its 2026 Dodd-Frank Act stress test results on June 24, 2026, based on the Federal Reserve's hypothetical Supervisory Severely Adverse Scenario. The projections show the firm's common equity tier 1 (CET1) ratio falling from 14.6% at the end of 4Q25 to a projected minimum of 12.4%, ending at 14.4% in 1Q28, and $70.2 billion of projected loan losses over nine quarters. The company states that these are hypothetical estimates, not forecasts of actual results.
Projected minimum CET1 ratio of 12.4%, versus 14.6% actual at 4Q25 and a 4.5% regulatory minimum
Nine-quarter projected pre-provision net revenue of $135.9 billion and provision for credit losses of $95.6 billion (1Q26 to 1Q28)
Projected net income before taxes of $11.4 billion and total projected loan losses of $70.2 billion
JPMorgan Chase Bank, N.A. projected minimum CET1 ratio of 13.2%
The Fund's Board of Trustees approved changes to its 80% investment policy on June 23, 2026, effective August 28, 2026. The policy now covers corporate debt obligations and income-producing investments, which may include those of non-corporate issuers, and the filing describes which instruments count as income-producing.
Board approved the policy change on June 23, 2026; effective date is August 28, 2026.
Fund invests at least 80% of net assets (plus borrowings for investment purposes) in corporate debt obligations and/or income-producing investments.
Fund may not change the 80% Policy without at least 60 days' written notice to shareholders.
Supplement dated June 24, 2026 updates the prospectus and statement of additional information (Exhibit 99.1).
Chemours agreed on June 23, 2026 to a proposed Consent Decree with the U.S. EPA and the West Virginia Department of Environmental Protection to resolve claims over PFAS emissions and other alleged activities at its Washington Works, Fayetteville Works and Chambers Works facilities. The settlement remains subject to court approval, and the company says it expects the expansion of its off-site drinking water programs to increase its existing environmental reserves, which could weigh on future results.
Civil penalty of $22.5 million, payable in three annual installments; $15 million was previously accrued
$90 million to fund additional PFAS mitigation projects or drinking water relief over the next 15 years
Separate resolution of West Virginia Rivers Coalition Clean Water Act suit from 2024 for less than $1 million
Settlement is subject to notice, comment and court approval and is not an admission of liability
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.